Drug Type Bacteriophage therapy |
Synonyms- |
Target |
Action inhibitors |
Mechanism PcrV inhibitors(Pseudomonas aeruginosa PvrV protein inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cystic Fibrosis | Phase 2 | United States | 29 Mar 2021 | |
Pseudomonas aeruginosa infection | Phase 2 | United States | 29 Mar 2021 |
Phase 1/2 | 8 | (Phage Therapy) | jkyfhvtblm(sozszqorct) = dtdstljxyd ubzejegxwr (bvpcyspmuy, 1.62) View more | - | 03 Mar 2023 | ||
Placebo (Placebo) | jkyfhvtblm(sozszqorct) = pwmjzubkuh ubzejegxwr (bvpcyspmuy, 1.77) View more |